The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007
Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs—its impact on health expenditure. Most formal studies have focused on the expenditure impacts of medical technology, partly because costs are more easily identified and quantified than are benefits. Moreover, most quantitative research relating to the impact of broad categories of technology on health outcomes has focused on pharmaceuticals. This is the first study that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure innovation—using data on over one million hospital discharges.
Volume (Year): 77 (2013)
Issue (Month): C ()
|Contact details of provider:|| Web page: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description|
|Order Information:|| Postal: http://www.elsevier.com/wps/find/supportfaq.cws_home/regional|
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Frank R. Lichtenberg & Gautier Duflos, 2008. "Pharmaceutical innovation and the longevity of Australians: a first look," NBER Working Papers 14009, National Bureau of Economic Research, Inc.
- Frank Lichtenberg, 2012. "Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7," PharmacoEconomics, Springer, vol. 30(3), pages 197-211, March.
- Frank Lichtenberg, 2011.
"The quality of medical care, behavioral risk factors, and longevity growth,"
International Journal of Health Economics and Management,
Springer, vol. 11(1), pages 1-34, March.
- Frank R. Lichtenberg, 2009. "The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth," NBER Working Papers 15068, National Bureau of Economic Research, Inc.
- Productivity Commission, 2005. "Impacts of Advances in Medical Technology in Australia," Research Reports, Productivity Commission, Government of Australia, number 17.
- Jonathan Skinner & John E. Wennberg, 1998.
"How Much is Enough? Efficiency and Medicare Spending in the Last Six Months of Life,"
NBER Working Papers
6513, National Bureau of Economic Research, Inc.
- Jonathan S. Skinner & John Wennberg, 2000. "How Much Is Enough? Efficiency and Medicare Spending in the Last Six Months of Life," NBER Chapters, in: The Changing Hospital Industry: Comparing For-Profit and Not-for-Profit Institutions, pages 169-194 National Bureau of Economic Research, Inc.
- Adriana Lleras-Muney & Frank R. Lichtenberg, 2010.
"Are the More Educated More LIkely to Use New Drugs?,"
in: Contributions in Memory of Zvi Griliches, pages 671-696
National Bureau of Economic Research, Inc.
- Adriana Lleras-Muney & Frank R. Lichtenberg, 2005. "Are the More Educated More Likely to Use New Drugs?," Annals of Economics and Statistics, GENES, issue 79-80, pages 671-696.
When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:77:y:2013:i:c:p:50-59. See general information about how to correct material in RePEc.
If references are entirely missing, you can add them using this form.